Search - tctmd.com

Displaying 721 - 740 of 1338

Sort: Relevancy | Date

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

Presentation TVT 2019

Minimalist Approach to Percutaneous Transaxillary TAVI: The M-Ax Approach

Presenter: Gautam Visveswaran

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Presenter: Axel Linke

June 13, 2019

Presentation TVT 2019

Severe AR After TAVI: A Unique Treatment Option

Presenter: Praveen Chandra

June 13, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Conference News EuroPCR 2019

Cath Lab Checklists a Means to Prevent Errors and Anticipate Problems Before They Arise

L.A. McKeown

June 04, 2019

Podcast TCTMD Talking Points

SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve Implantation

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

Presentation EuroPCR 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presenter: IJ. Amat-Santos

May 21, 2019

Presentation EuroPCR 2019

Ten year follow-up of patients treated with transcatheter aortic valve implantation

Presenter: Janarthanan Sathananthan

May 21, 2019

Presentation EuroPCR 2019

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Presenter: Mohamed Abdel-Wahab

May 21, 2019

News Daily News

Women Have Higher Risk of TAVR-Related Pericardial Complications

Todd Neale

April 26, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

Presentation Fellows 2019

TAVI – Progress, Pseudoprogress and Future Directions

Presenter: Susheel Kodali

April 14, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

Presentation CIT 2019

TAVI China Perspectives

Presenter: Mao Chen

March 28, 2019

Presentation CIT 2019

Coronary Protection in Patients undergoing TAVI with Low Coronary Ostia

Presenter: Tullio Palmerini

March 28, 2019

Advertisement

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Minimalist Approach to Percutaneous Transaxillary TAVI: The M-Ax Approach

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Severe AR After TAVI: A Unique Treatment Option

Potential Warning Signs Seen for NOAC Use After TAVR

Cath Lab Checklists a Means to Prevent Errors and Anticipate Problems Before They Arise

SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve Implantation

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Ten year follow-up of patients treated with transcatheter aortic valve implantation

Five-year outcomes after TAVI with balloon-expandable vs. self-expanding valves: Results from the CHOICE randomised clinical trial

Women Have Higher Risk of TAVR-Related Pericardial Complications

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

TAVI – Progress, Pseudoprogress and Future Directions

Latest Observational Data Support TAVR Durability Through 7 Years

TAVI China Perspectives

Coronary Protection in Patients undergoing TAVI with Low Coronary Ostia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content